Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,100Revenue (TTM) $M43.2Net Margin (%)-453.4Altman Z-Score-4.2
Enterprise Value $M2,166EPS (TTM) $-0.9Operating Margin %-342.0Piotroski F-Score4
P/E(ttm)--Beneish M-Score-3.8Pre-tax Margin (%)-453.3Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio3.3Cash flow > EarningsY
Price/Sales45.75-y EBITDA Growth Rate %--Current Ratio3.4Lower Leverage y-yN
Price/Free Cash Flow43.8y-y EBITDA Growth Rate %--ROA % (ttm)-57.0Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M229ROIC % (ttm)-212.7Gross Margin Increase y-yN

Gurus Latest Trades with EXEL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
EXELCharles Brandes 2016-03-31 Sold Out $3.64 - $5.64
($4.25)
$ 9.18116%Sold Out0
EXELCharles Brandes 2015-12-31 Reduce$4.79 - $6.33
($5.59)
$ 9.1864%Reduce -44.88%14,000
EXELCharles Brandes 2015-06-30 Buy $2.57 - $4.03
($3.24)
$ 9.18183%New holding25,400
EXELFirst Eagle Investment 2014-06-30 Sold Out -0.0038%$3.22 - $3.8
($3.45)
$ 9.18166%Sold Out0
EXELFirst Eagle Investment 2014-03-31 Reduce-0.01%$3.38 - $8.24
($6.84)
$ 9.1834%Reduce -65.91%400,000
EXELFirst Eagle Investment 2012-09-30 Add0.02%$4.28 - $6.45
($5.29)
$ 9.1874%Add 422.58%1,175,800
EXELFirst Eagle Investment 2012-03-31 Add$4.49 - $6.47
($5.14)
$ 9.1879%Add 125.00%225,000
EXELFirst Eagle Investment 2011-12-31 Buy $3.95 - $7.81
($5.01)
$ 9.1883%New holding100,000
EXELCarl Icahn 2011-09-30 Sold Out -0.43%$5.5 - $9.22
($7.34)
$ 9.1825%Sold Out0
EXELFirst Eagle Investment 2011-03-31 Sold Out -0.01%$7.22 - $12.45
($9.95)
$ 9.18-8%Sold Out0
EXELFirst Eagle Investment 2010-12-31 Buy 0.01%$3.98 - $9.08
($5.66)
$ 9.1862%New holding280,000
EXELFirst Eagle Investment 2009-12-31 Sold Out -0.02%$5.33 - $8
($6.84)
$ 9.1834%Sold Out0
EXELFirst Eagle Investment 2009-09-30 Buy 0.02%$4.4 - $6.99
($5.65)
$ 9.1862%New holding274,700
EXELFirst Eagle Investment 2009-06-30 Sold Out -0.01%$4.16 - $5.55
($4.87)
$ 9.1889%Sold Out0
EXELFirst Eagle Investment 2009-03-31 Reduce$4.32 - $5.85
($4.8)
$ 9.1891%Reduce -25.67%144,800
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

EXEL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


EXEL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
WILLSEY LANCEDirector 2016-05-11Buy60,000$4.9780.08view
WILLSEY LANCEDirector 2015-12-11Buy100,000$4.8983.03view
Lamb PeterEVP, Discovery Research & CSO 2015-10-16Sell51,549$5.854.31view
Lamb PeterEVP, Discovery Research & CSO 2015-10-13Sell300,876$5.8453.25view
MARCHESI VINCENT TDirector 2014-09-17Buy20,000$1.71423.39view
WILLSEY LANCEDirector 2013-08-29Buy10,000$5.1573.79view
MARCHESI VINCENT TDirector 2012-12-20Buy4,000$4.6891.24view
MARCHESI VINCENT TDirector 2012-12-19Buy6,000$4.7289.62view
Schwab GiselaEVP and Chief Medical Officer 2012-12-10Buy25,000$4.39103.87view
MARCHESI VINCENT TDirector 2012-06-14Sell7,000$5.1374.46view

Quarterly/Annual Reports about EXEL:

News about EXEL:

Articles On GuruFocus.com
The Best-Performing Non-S&P Stocks of 2015 Dec 30 2015 
5-year lows: Synta Pharmaceuticals Inc, Exelixis Inc, Entropic Communications Inc, and Aeropostale I Dec 28 2014 
5-year lows: National Presto Industries, Ennis Inc, Landauer Inc, and Exelixis Inc. Sep 28 2014 
Weekly 3-Year Low Highlights: UAN, CLD, EXEL, QNST Sep 06 2014 
Five-Year Lows: Rentech Nitrogen Partners LP, SandRidge Permian Trust, Millennial Media Inc., Exelix May 05 2014 
5 Resilient Biotech Stocks to Buy for 2012 Feb 28 2012 
Exelixis Inc. Reports Operating Results (10-K) Feb 22 2011 
Exelixis Inc. (EXEL) CFO Frank Karbe buys 16,500 Shares Aug 25 2010 
Exelixis Inc. Reports Operating Results (10-Q) Aug 05 2010 
Exelixis Inc. Reports Operating Results (10-Q) May 11 2010 

More From Other Websites
Ipsen and its Partner Exelixis Receive Positive CHMP Opinion for Cabometyx™ (Cabozantinib) for the... Jul 22 2016
Ipsen and its Partner Exelixis Receive Positive CHMP Opinion for Cabometyx™ (Cabozantinib) for the... Jul 22 2016
Ipsen and its partner Exelixis receive positive CHMP opinion for Cabometyx™ (cabozantinib) for the... Jul 22 2016
Exit of Biogen CEO George Scangos could be big for Bay Area biotechs Jul 21 2016
Exelixis to Release Second Quarter 2016 Financial Results on Wednesday, August 3, 2016 Jul 12 2016
Exelixis to Release Second Quarter 2016 Financial Results on Wednesday, August 3, 2016 Jul 12 2016
Biotech Stock Mailbag: Heron, Exelixis Jul 08 2016
Merger and Acquisition Activity in the Biotech Sector Potentially on the Rise after Pfizers $5.2... Jul 01 2016
Merger and Acquisition Activity in the Biotech Sector Potentially on the Rise after Pfizers $5.2... Jun 30 2016
Zacks.com featured highlights: Arcos Dorados Holdings, Corcept Therapeutics, Exelixis, Hecla Mining... Jun 29 2016
Explosive Stocks Under $10 Jun 28 2016
Biotech Stock Bounce Picks Up Momentum Jun 23 2016
'Mad Money' Lightning Round: I'm Sticking With Wells Fargo Jun 15 2016
Research Coverage Scans Stocks on the Biotechnology Industry for Today Jun 08 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)